Primary Prevention Aspirin, Lipoprotein(a), and Cardiorenal Outcomes in Chronic Kidney Disease: Chronic Renal Insufficiency Cohort

By afschroeder • August 22, 2025

Razavi AC, Chen J, Yang W, Sha D, Dzaye O, Bhatia HS, Tsimikas S, Lash JP, Kansal M, Rincon-Choles H, Vaccarino V, Jacobson TA, Budoff MJ, Blumenthal RS, Whelton SP, Sperling LS, Blaha MJ, He J; CRIC Study Investigators. Primary Prevention Aspirin, Lipoprotein(a), and Cardiorenal Outcomes in Chronic Kidney Disease: Chronic Renal Insufficiency Cohort. JACC Adv. 2025 Aug 19;4(9):102068. doi: 10.1016/j.jacadv.2025.102068. Epub ahead of print. PMID: 40839904.

Tags: Aspirin, Cardiology/Epi, cardiovascular diseases, Chronic kidney disease, Harbor UCLA, lipoprotein(a), Publications

Effects of hemodialysis on hemoglobin oxygen affinity and cardiac function

Sharma S, Nguyen KL, Salusky IB, Ganz T, Ix JH. Effects of hemodialysis on hemoglobin oxygen affinity and cardiac function. Clin Kidney J. 2025 Jul[...]

Circulating Trimethylamine N-Oxide and Growth Rate of Abdominal Aortic Aneurysms and Surgical Risk

Cameron SJ, Li XS, Benson TW, Conrad KA, Wang Z, Fleifil S, Maegdefessel L, Mani K, Björck M, Scalise A, Pham M, Shim S, Wanhainen[...]

Comparison of Fixed vs Age-Adjusted NT-proBNP Cutoffs to Define Pre-Heart Failure

Cai A, Liu L, Feng Y, Li L, Bozkurt B, Januzzi JL Jr, Lam CSP, Fonarow GC, Pandey A, Chen LY, Cheng Y, Bayes-Genis A.[...]